The future role of inotropic drugs.
Inotropic drugs have not, as yet, been shown in double-blind, randomised and placebo-controlled trials to be of value in the treatment of heart failure. There are theoretical reasons why inotropic drugs may initiate arrhythmias, worsen ischaemia and possibly even increase mortality.
D002316:Cardiotonic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003326:Coronary Circulation / Q000187:drug effects; D004077:Digoxin / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans
D002316:Cardiotonic Agents; D004077:Digoxin